Clinical trial
A Prospective, Multi-center, Randomized Parallel Controlled Study on the Safety and Effectiveness of the Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations
NCT05058482 is registered in ClinicalTrials.gov with Suzhou Hengruihongyuan Medical Technology Co. LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, Randomized Parallel Controlled Study on the Safety and Effectiveness of the Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations
- Lead sponsor
- Suzhou Hengruihongyuan Medical Technology Co. LTD
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 2, 2021
- Completion date
- October 17, 2024
- Enrollment
- 116 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.